TOSI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.720
EU - Europa 16.723
AS - Asia 14.645
SA - Sud America 1.985
Continente sconosciuto - Info sul continente non disponibili 419
AF - Africa 353
OC - Oceania 56
Totale 66.901
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.159
GB - Regno Unito 4.584
IT - Italia 4.529
SG - Singapore 4.028
CN - Cina 3.961
SE - Svezia 3.078
HK - Hong Kong 1.892
BR - Brasile 1.478
VN - Vietnam 1.458
DE - Germania 919
BD - Bangladesh 734
RU - Federazione Russa 635
FI - Finlandia 614
TR - Turchia 605
UA - Ucraina 592
FR - Francia 545
KR - Corea 476
IN - India 383
CA - Canada 270
BG - Bulgaria 229
NL - Olanda 183
ID - Indonesia 165
AR - Argentina 156
IQ - Iraq 140
JP - Giappone 130
MX - Messico 127
ES - Italia 117
IE - Irlanda 111
ZA - Sudafrica 103
PL - Polonia 84
BE - Belgio 83
PK - Pakistan 82
CO - Colombia 81
EC - Ecuador 80
RO - Romania 78
AE - Emirati Arabi Uniti 71
MY - Malesia 67
LT - Lituania 65
VE - Venezuela 62
CH - Svizzera 53
EG - Egitto 47
IR - Iran 46
IL - Israele 45
AU - Australia 44
UZ - Uzbekistan 40
CL - Cile 39
MA - Marocco 39
PH - Filippine 37
PY - Paraguay 34
CR - Costa Rica 32
DZ - Algeria 31
TN - Tunisia 31
JM - Giamaica 29
JO - Giordania 29
AT - Austria 28
SA - Arabia Saudita 28
CZ - Repubblica Ceca 27
GR - Grecia 26
KE - Kenya 25
NP - Nepal 24
TW - Taiwan 24
TH - Thailandia 23
PT - Portogallo 22
AZ - Azerbaigian 21
KZ - Kazakistan 20
EE - Estonia 19
PE - Perù 18
UY - Uruguay 18
BO - Bolivia 17
ET - Etiopia 17
TT - Trinidad e Tobago 17
HN - Honduras 15
SN - Senegal 15
DK - Danimarca 14
EU - Europa 14
BY - Bielorussia 13
AL - Albania 11
DO - Repubblica Dominicana 11
HU - Ungheria 11
LB - Libano 11
NZ - Nuova Zelanda 11
OM - Oman 11
PR - Porto Rico 11
KG - Kirghizistan 10
PA - Panama 10
RS - Serbia 10
NO - Norvegia 9
KH - Cambogia 8
LY - Libia 8
NI - Nicaragua 8
PS - Palestinian Territory 8
AM - Armenia 7
GT - Guatemala 7
HR - Croazia 7
LK - Sri Lanka 7
BZ - Belize 6
CY - Cipro 6
GE - Georgia 6
KW - Kuwait 6
LA - Repubblica Popolare Democratica del Laos 6
Totale 66.381
Salva come PNG Salva come JPEG
Città #
Southend 3.452
Ashburn 2.998
Santa Clara 2.787
Singapore 2.452
Fairfield 2.223
Hong Kong 1.846
Stockholm 1.816
Chandler 1.671
Woodbridge 1.618
Chicago 1.297
San Jose 1.292
Hefei 1.276
Jacksonville 1.144
Houston 1.020
Seattle 969
Wilmington 940
Council Bluffs 924
Dearborn 877
Los Angeles 841
Beijing 797
Ann Arbor 776
Nyköping 761
Cambridge 758
London 612
Modena 546
Ho Chi Minh City 502
Seoul 405
Salt Lake City 401
New York 384
Helsinki 380
The Dalles 380
Milan 376
Izmir 330
Hanoi 324
Dallas 281
Princeton 235
Sofia 216
San Diego 206
Eugene 201
Lauterbourg 197
Rome 193
Bologna 186
Buffalo 183
Tampa 174
Moscow 169
Elk Grove Village 168
São Paulo 143
Shanghai 139
Munich 124
Redwood City 121
Orem 117
Columbus 116
Jakarta 114
Frankfurt am Main 107
Tokyo 103
Phoenix 101
Bremen 94
Falls Church 93
Lancaster 92
Des Moines 86
Dublin 85
Fremont 84
Reggio Emilia 80
Sterling 79
Miami 76
Naples 72
Brussels 69
Chennai 69
Florence 67
Boardman 65
Parma 64
Atlanta 58
Brooklyn 57
Da Nang 57
Toronto 57
Guangzhou 56
Montreal 55
Warsaw 55
Haiphong 54
Dulles 53
Johannesburg 51
Detroit 49
Baghdad 48
Catania 46
Denver 46
Nanjing 46
Turin 45
Amsterdam 43
Bari 42
Rio de Janeiro 42
Washington 42
Como 41
Mexico City 40
Palermo 40
Tulare 39
Norwalk 38
Manchester 37
Mumbai 37
Napoli 37
Boston 36
Totale 45.291
Salva come PNG Salva come JPEG
Nome #
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.045
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 607
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 523
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 502
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 490
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 476
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 472
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 464
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 455
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 445
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 440
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 439
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 428
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 428
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 427
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 426
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 423
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 420
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 416
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 415
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 412
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 410
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 405
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 405
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 399
Chemo-enzymatic synthesis of levodropropizine 399
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 395
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 395
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 391
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 387
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 384
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 384
Polymeric nanoparticles for the drug delivery to the central nervous system 379
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 376
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 375
Nanoparticle transport across the blood brain barrier 375
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 374
Vegetable cells in Papanicolaou-stained cervical smears 373
Nanomedicine: the future for advancing medicine and neuroscience 373
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 372
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 371
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 369
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 367
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 366
Brain targeting with polymeric nanoparticles: which administration route should we take? 366
Protein corona and nanoparticles: How can we investigate on? 364
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 357
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 354
Advances and perspectives for Central Nervous System drug delivery: the interface between nanotechnology and neuroscience 353
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 353
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 352
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 351
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 351
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 346
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 345
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 344
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 342
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 341
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 341
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 341
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 340
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 339
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 338
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 337
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 336
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 334
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 330
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 330
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 330
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 329
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 329
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 329
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 329
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 328
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 326
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 326
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 322
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 320
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 318
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 317
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 316
Functionalization of liposomes: microscopical methods for preformulative screening 315
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 314
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 312
Colloidal systems for CNS drug delivery 311
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 310
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 306
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 305
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 303
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 302
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 295
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 293
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 291
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 284
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 282
Application of poly-L-lactide screws in flat foot surgery: Histological and radiological aspects of bio-absorption of degradable devices 282
Brain targeting by engineered nanoparticles 281
Ketorolac tromethamine liposomes: Encapsulation and release studies 279
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 279
Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers 279
Totale 38.104
Salva come PNG Salva come JPEG
Categoria #
all - tutte 250.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 250.720
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.371 0 0 379 242 154 210 213 222 483 320 642 506
2022/20234.655 577 548 362 472 544 622 125 411 528 74 190 202
2023/20243.511 165 197 221 285 793 356 401 418 109 107 169 290
2024/202510.855 500 175 228 827 2.043 1.474 851 771 1.053 466 1.099 1.368
2025/202623.344 1.308 808 1.504 2.778 4.373 1.321 2.161 1.026 3.784 1.901 1.235 1.145
2026/20272.289 526 1.261 502 0 0 0 0 0 0 0 0 0
Totale 66.901